Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Divergence Raises $12 million

by Marc S. Reisch
February 23, 2009 | A version of this story appeared in Volume 87, Issue 8

Divergence has raised $12 million from investors to advance its nematicide program. The St. Louis-based firm claims it has discovered the first new molecules to control plant parasitic nematodes, a class of pest that the firm says causes billions of dollars in crop loss annually and widespread disease in humans and animals. The 10-year-old biotechnology firm applies genomics and informatics to develop parasite controls. Working with Monsanto, Divergence last year completed the genome for the soybean cyst nematode and made it publicly available.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.